Cargando…
Cost-Effectiveness of Angiotensin-Converting Enzyme Inhibitors for the Prevention of Diabetic Nephropathy in The Netherlands – A Markov Model
OBJECTIVE: Type 2 diabetes is the main cause of end-stage renal disease (ESRD) in Europe and the USA. Angiotensin-converting enzyme (ACE) inhibitors have a potential to slow down the progression of renal disease and therefore provide a renal-protective effect. The aim of our study was to assess the...
Autores principales: | Adarkwah, Charles Christian, Gandjour, Afschin, Akkerman, Maren, Evers, Silvia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3191181/ https://www.ncbi.nlm.nih.gov/pubmed/22022539 http://dx.doi.org/10.1371/journal.pone.0026139 |
Ejemplares similares
-
A parsimonious model to validate cost-effectiveness analyses on preventive health care
por: Gandjour, Afschin
Publicado: (2021) -
A Model-Based Estimate of the Cost-Effectiveness Threshold in Germany
por: Gandjour, Afschin
Publicado: (2023) -
Long COVID: Costs for the German economy and health care and pension system
por: Gandjour, Afschin
Publicado: (2023) -
A retrospective study of the effects of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in diabetic nephropathy
por: Pathak, Jahnavi V., et al.
Publicado: (2015) -
Role of angiotensin converting enzyme and angiotensinogen gene polymorphisms in angiotensin converting enzyme inhibitor-mediated antiproteinuric action in type 2 diabetic nephropathy patients
por: Aggarwal, Neerja, et al.
Publicado: (2017)